sechenovSechenov Medical JournalСеченовский вестник2218-73322658-3348Сеченовский Университетsechenov-596Research ArticleHISTORY OF MEDICINEИСТОРИЯ МЕДИЦИНЫFate of doctors and nazismСудьбы врачей и нацизмДамулинИ. В.DamulinI. V.

Дамулин Игорь Владимирович - доктор медицинских наук, профессор кафедры нервных болезней и нейрохирургии лечебного факультета.

119021, Москва,  ул. Россолимо, д. 11, стр. 1

Телефон: +7 (499) 248-63-73

Igor V. Damulin - Doctor of Medical Science, Professor, the Department of Nervous Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University.

11/1, Rossolimo str., Moscow, 119021

Tel.: +7 (499) 248-63-73

damulin@mmascience.ruШуруповаР. В.ShurupovaR. V.

Доктор социологических наук, кандидат педагогических наук, профессор, доцент кафедры теории и технологии обучения в высшей школе.

Doctor of Social Science, Associate Professor, Department of Theory and Technology of Higher School Training, I.M. Sechenov First Moscow State Medical University.

СтруценкоА. А.StrutsenkoA. A.

Кандидат медицинских наук, доцент кафедры нервных болезней и нейрохирургии Медицинского института.

Candidate of Medical Science, Associate Professor, the Department of Nervous Diseases and Neurosurgery, Medical Institute, Russian Peoples' Friendship University.

Первый Московский государственный медицинский университет имени И.М. СеченоваРоссияI.M. Sechenov First Moscow State Medical UniversityRussian FederationРоссийский университет дружбы народовРоссияRussian Peoples' Friendship UniversityRussian Federation201630062016026369Copyright © Damulin I.V., Shurupova R.V., Strutsenko A.A., 20162016Дамулин И.В., Шурупова Р.В., Струценко А.А.Damulin I.V., Shurupova R.V., Strutsenko A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sechenovmedj.com/jour/article/view/596

This article discusses the importance of competence building in managerial health care staff, and the development of appropriate competence building models (competence profiles). The authors did expert interviews of 16 professors of the organizational departments at Razumovsky Saratov State Medical University. We determined importance of the competencies  presented in the State educational standard for «Health care organization and public health» programs for the department heads; deputy heads (vice-head) and head physicians (chiefs) of medical organizations, as well as what future graduates need «to know», «be able to» and «to have», i.e. formulated appropriate competence building models. These models can be used both to develop training programs and healthcare personnel policy.

В статье рассматривается судьба врачей, оставивших свой след в виде эпонимических названий в области нейронаук, которые жили в Германии во времена нацистского режима и активно с ним боролись, а также тех, кто активно сотрудничал с нацистами. Память о людях, которые боролись с нацистским режимом должна остаться как в научной медицинской литературе, так и в обычной медицинской практике, в том числе в виде эпонимов. И в то же время, если использование того или иного эпонимического названия заболевания или синдрома связано с нарушением этических норм первооткрывателем, применение подобных названий представляется аморальным, а само название следует принудительно «забыть», вычеркнув его не просто из практической деятельности и из медицинской литературы, но и из памяти. Подчеркивается важность этической стороны в деятельности медиков.

Эпонимыборьба с нацизмомврачисвязанные с нацистамиэвтаназиягеноцидэтика в нейронаукахмедицинские эксперименты на людяхEponymsthe struggle against NazismNazi doctorseuthanasiagenocideethic in neurosciencemedical experimentations on humansReferencesZeidman L.A. Neuroscience in Nazi Europe Part II: Resistance against the Third Reich. Can. J. of Neurol. Sci. 2011; 38: 826–838.Zeidman L.A. Neuroscience in Nazi Europe Part II: Resistance against the Third Reich. Can. J. of Neurol. Sci. 2011; 38: 826–838.Kater M.H. Some ramifications of good and evil medicine in Nazi Germany and beyond. Can. J. of Neurol. Sci. 2011; 38: 808–809.Kater M.H. Some ramifications of good and evil medicine in Nazi Germany and beyond. Can. J. of Neurol. Sci. 2011; 38: 808–809.Zeidman L.A. Neuroscience in Nazi Europe Part I: Eugenics, human experimentation, and mass murder. Can. J. Neurol. Sci. 2011; 38: 696–703.Zeidman L.A. Neuroscience in Nazi Europe Part I: Eugenics, human experimentation, and mass murder. Can. J. Neurol. Sci. 2011; 38: 696–703.Kondziella D. Thirty neurological eponyms associated with the Nazi Era. Eur. Neurol. 2009; 62: 56–64.Kondziella D. Thirty neurological eponyms associated with the Nazi Era. Eur. Neurol. 2009; 62: 56–64.Strous R.D., Edelman M.C. Eponyms and the Nazi era: time to remember and time for change. Israel Med. Association J. 2007; 9: 207–214.Strous R.D., Edelman M.C. Eponyms and the Nazi era: time to remember and time for change. Israel Med. Association J. 2007; 9: 207–214.Urbano F.L. Tinel’s sign and Phalen’s maneuver: Physical signs of carpal Tunnel syndrome. Hospital Physician. 2000; July: 39–44.Urbano F.L. Tinel’s sign and Phalen’s maneuver: Physical signs of carpal Tunnel syndrome. Hospital Physician. 2000; July: 39–44.Pross C. Breaking through the postwar coverup of Nazi doctors in Germany. J. Med. Ethics. 1991; 17 (Suppl.): 13–16.Pross C. Breaking through the postwar coverup of Nazi doctors in Germany. J. Med. Ethics. 1991; 17 (Suppl.): 13–16.Colaianni A. A long shadow: Nazi doctors, moral vulnerability and contemporary medical culture. J. Med. Ethics. 2012; 38: 435–438.Colaianni A. A long shadow: Nazi doctors, moral vulnerability and contemporary medical culture. J. Med. Ethics. 2012; 38: 435–438.Pearce J.M.S. Neurodegeneration with brain iron accumulation: a cautionary tale. Eur. Neurol. 2006; 56: 66–68.Pearce J.M.S. Neurodegeneration with brain iron accumulation: a cautionary tale. Eur. Neurol. 2006; 56: 66–68.Shevell M. Hallervorden and History. New Engl. J. Med. 2003; 348: 3–4.Shevell M. Hallervorden and History. New Engl. J. Med. 2003; 348: 3–4.De Stefano N.,Dotti M.T.,Mortilla M., Federico A. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinousxanthomatosis. Brain. 2001; 124 (1): 121–131.De Stefano N.,Dotti M.T.,Mortilla M., Federico A. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinousxanthomatosis. Brain. 2001; 124 (1): 121–131.Dotti M.T., Lutjohann D., von Bergmann K., Federico A. Normalisation of serum cholestanol concentration in a patient with cerebrotendinousxanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDH apheresis. Neurol. Sci. 2004; 25: 185–191.Dotti M.T., Lutjohann D., von Bergmann K., Federico A. Normalisation of serum cholestanol concentration in a patient with cerebrotendinousxanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDH apheresis. Neurol. Sci. 2004; 25: 185–191.Moghadasian M.H., Salen G., Frohlich J.J., Scudamore C.H. Cerebrotendinousxanthomatosis. A rare disease with diverse manifestations. Arch. Neurol. 2002; 59: 527–529.Moghadasian M.H., Salen G., Frohlich J.J., Scudamore C.H. Cerebrotendinousxanthomatosis. A rare disease with diverse manifestations. Arch. Neurol. 2002; 59: 527–529.Verrips A., Hoefsloot L.H.,Steenbergen G.C.H., Theelen J.P., Wevers R.A., Gabreels F.J.M., van Engelen B.G., van den Heuvel L.P. Clinical and molecular genetic characteristics of patients with cerebrotendinousxanthomatosis. Brain. 2000; 123 (5): 908–919.Verrips A., Hoefsloot L.H.,Steenbergen G.C.H., Theelen J.P., Wevers R.A., Gabreels F.J.M., van Engelen B.G., van den Heuvel L.P. Clinical and molecular genetic characteristics of patients with cerebrotendinousxanthomatosis. Brain. 2000; 123 (5): 908–919.

The authors declare that there are no conflicts of interest present.